Date published: 2026-5-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

TBK1 Inhibitors

TBK1 inhibitors belong to a distinct chemical class that has garnered significant attention within the realm of molecular research due to their intricate role in cellular signaling pathways. These inhibitors are specifically designed to target and modulate the activity of TANK-binding kinase 1 (TBK1), a serine/threonine kinase found in the cytoplasm of cells. TBK1 is a pivotal component of innate immune responses and cellular homeostasis, as it plays a crucial role in orchestrating the activation of various downstream signaling cascades in response to pathogenic invasion and cellular stressors. Structurally, TBK1 inhibitors are carefully crafted molecules that interact with the active site of the kinase, thwarting its enzymatic activity and subsequent downstream signaling events. From a molecular perspective, TBK1 inhibitors typically comprise a diverse array of chemical scaffolds, often incorporating elements that facilitate binding to the kinase's active site.

The design of these inhibitors takes into account the complex three-dimensional structure of TBK1, aiming to exploit specific interactions that occur between the inhibitor and the kinase's residues. This interplay leads to the interruption of key phosphorylation events within the TBK1-mediated pathways, curtailing the activation of critical transcription factors and regulators that influence immune responses, autophagy, and cell growth. Consequently, TBK1 inhibitors hold the potential to unravel the intricate network of cellular processes governed by this kinase, shedding light on previously unexplored avenues of cell biology.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

BX 795

702675-74-9sc-281689
sc-281689A
sc-281689C
sc-281689B
sc-281689D
sc-281689E
2 mg
5 mg
10 mg
25 mg
50 mg
100 mg
$219.00
$273.00
$331.00
$495.00
$882.00
$1489.00
5
(1)

A small molecule inhibitor that was one of the first compounds discovered to inhibit TBKIt was found to have potential in suppressing inflammatory responses by inhibiting the activation of the TBK1-IRF3 pathway.

Amlexanox

68302-57-8sc-217630
10 mg
$160.00
2
(1)

Originally used for asthma and aphthous ulcers, amlexanox was found to inhibit TBK1 and IKKε kinases. It has been investigated for its potential in reducing inflammation in various diseases.

MRT67307

1190378-57-4sc-507433
10 mg
$234.00
(0)

A selective inhibitor of TBK1/IKKε that has shown promise in research studies for targeting autoimmune disorders and certain cancers.

Cyt387

1056634-68-4sc-364733
sc-364733A
10 mg
50 mg
$214.00
$612.00
2
(1)

While primarily developed as a JAK1/JAK2 inhibitor, CYT387 was also found to inhibit TBKIt has been investigated for its potential in myelofibrosis and other hematological malignancies.

NH125

278603-08-0sc-203037
5 mg
$191.00
1
(1)

NH125 is a potent inhibitor of both TBK1 and IKKε kinases. It has been researched for its potential to modulate immune responses and inflammation.

CX-5461

1138549-36-6sc-507275
5 mg
$245.00
(0)

Although initially developed as a Pol I inhibitor for cancer, CX-5461 was found to inhibit TBKIt has shown potential in modulating innate immune responses.